Overweight and obesity: A review of their relationship to metabolic syndrome, cardiovascular disease, and cancer in South America

Nutrition Reviews

Volumn 71, Issue 3, 2013, Pages 168-179

  Aballay, Laura R ^a   Eynard, Aldo R ^a,b   Díaz, María del Pilar ^a   Navarro, Alicia ^a   Muñoz, Sonia E ^a,b  

^a FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

^b Universidad Nacional de Río Cuarto Consejo Nacional de Investigaciones Científicas y Técnicas   (Argentina)

Author keywords

Latin America; Non transmissible diseases; Obesity; Overweight; South America

Indexed keywords

AGING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COLORECTAL CANCER; COMORBIDITY; CORONARY ARTERY ATHEROSCLEROSIS; ETHNICITY; EXERCISE; FOOD INTAKE; HEALTH BEHAVIOR; HUMAN; HYPERTENSION; LIFESTYLE; METABOLIC SYNDROME X; NEOPLASM; OBESITY; REVIEW; RURAL AREA; SOUTH AMERICA; URBAN AREA; WEIGHT CONTROL; WEIGHT GAIN;

AGING; CARDIOVASCULAR DISEASES; HUMANS; LIFE STYLE; METABOLIC SYNDROME X; NEOPLASMS; OBESITY; OVERWEIGHT; PREVALENCE; RISK FACTORS; SOUTH AMERICA;

EID: 84874482075     PISSN: 00296643     EISSN: 17534887     Source Type: Journal    
DOI: 10.1111/j.1753-4887.2012.00533.x     Document Type: Review

References (186)

1. Swinburn BA, Sacks G, Hall KD, etal. The global obesity pandemic: shaped by global drivers and local environments. Lancet. 2011;378:804-814.
2. Drewnowski A, Popkin BM. The nutrition transition: new trends in the global diet. Nutr Rev. 1997;55:31-43.
3. Popkin BM. The nutrition transition in low-income countries: an emerging crisis. Nutr Rev. 1994;52:285-298.
4. Montero JC. Epidemiología de la obesidad en siete países de América Latina [in Spanish]. Form Contin Nutr Obes. 2002;5:325-330.
5. World Health Organization. The Global Health Observatory. 2012; Available at: http://www.who.int/gho/en/index.html. Accessed 9 November 2012.
6. Aballay LR, Osella AR, Celi A, etal. Overweight and obesity: prevalence and their association with some social characteristics in a random sample population-based study in Córdoba city, Argentina. Obes Res Clin Pract. 2009;3:75-83.
7. Albala C, Vio F, Kain J, etal. Nutrition transition in Latin America: the case of Chile. Nutr Rev. 2001;59:170-176.
8. Peña M, Bacallao J. La obesidad y sus tendencias en la región [in Spanish]. Rev Panam Salud Publica. 2001;10:75-78.
9. Mathes WF, Kelly SA, Pomp D. Advances in comparative genetics: influence of genetics on obesity. Br J Nutr. 2011;106(Suppl 1):S1-S10.
10. NHLBI Obesity Education Initiative Expert Panel on the Identification, Evaluation, and Treatment of Obesity in Adults. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. Report No. 98-4083. Bethesda, MD: National Heart, Lung, and Blood Institute; 1998. Available at: http://www.ncbi.nlm.nih.gov/books/NBK2003/. Accessed 18 October 2012.
11. Fernández Real JM, Catalán V, Moreno Navarrete JM, etal. Study of caveolin-1 gene expression in whole adipose tissue and its subfractions and during differentiation of human adipocytes. Nutr Metab. 2010;7:1-9.
12. Guerrero-Millo M. Adipose tissue hormones. J Endocrinol. 2002;25:855-861.
13. Booth ML, Chey T, Wake M, etal. Change in the prevalence of overweight and obesity among young Australians, 1969-1997. Am J Clin Nutr. 2003;77:29-36.
14. Dyer JS, Rosenfeld CR. Metabolic imprinting by prenatal, perinatal, and postnatal overnutrition: a review. Semin Reprod Med. 2011;29:266-276.
15. Cummings DE, Schwartz MW. Genetics and pathophysiology of human obesity. Annu Rev Med. 2003;54:453-471.
16. Barría RM, Amigo H. Nutrition transition: a review of Latin American profile. Arch Latinoam Nutr. 2006;56:3-11.
17. Popkin BM. Nutrition transition and obesity in the developing world. J Nutr. 2001;131:S881-S886.
18. Organización Mundial de la Salud. Dieta, nutrición y prevención de enfermedades crónicas [in Spanish]. 2003; Available at: ftp://ftp.fao.org/docrep/fao/006/ac911s/ac911s00.pdf. Accessed 31 October 2012.
19. Monteiro C. La Transición Epidemiológica en el Brasil. In: Peña M, Bacallao J, eds. La Obesidad en la Pobreza: un nuevo reto para la salud pública [in Spanish]. Washington, DC: Organización Panamericana de la Salud, Publicación científica N°576; 2000:73-83.
20. López de Blanco M, Carmona A. La Transición alimentaria y nutricional: un reto en el siglo XXI [in Spanish]. An Venez Nutr. 2005;18:90-104.
21. Roca L, Mejía Salas H. Prevalence and risk factors associated with obesity and overweight. Rev Soc Bol Ped. 2008;47:8-12.
22. Yepes R. La obesidad en el Ecuador en tempranas edades de la vida [in Spanish]. Rev Fac Ciencias Médicas. 2005;30:20-24.
23. Organización Mundial de la Salud. Régimen alimentario, nutrición y actividad física [in Spanish]. 2004; Available at: http://www.who.int/dietphysicalactivity/strategy/eb11344/strategy_spanish_web.pdf. Accessed 31 October 2012.
24. Castro Burbano J, Fornasini M, Acosta M. Prevalence and risk factors for overweight among school girls 12 to 19 years old in a semi-urban region of Ecuador. Rev Panam Salud Publica. 2003;13:277-284.
25. Yepez R, Carrasco F, Baldeon ME. Prevalencia de sobrepeso y obesidad en estudiantes adolescentes ecuatorianos del área urbana [in Spanish]. Arch Latinoam Nutr. 2008;58:139-143.
26. Kovalskys I, Bay L, Herscovci C, etal. Prevalencia de obesidad en una población de 10 a 19 años en la consulta pediátrica [in Spanish]. Arch Argent Pediatr. 2003;101:441-447.
27. Filozof C, Gonzalez C, Sereday M, etal. Obesity prevalence and trends in Latin-American countries. Obes Rev. 2001;2:99-106.
28. Ministerio de Salud, Presidencia de la Nación. Encuesta Nacional de Nutrición y Salud [in Spanish]. 2007; Available at: http://msal.gov.ar/htm/Site/ennys/pdf/ENNyS_Documento-de-resultados-2007-II.pdfhttp://msal.gov.ar/htm/Site/ennys/pdf/ENNyS_Documento-de-resultados-2007-II.pdf%20. Accessed 9 November 2012.
29. Ministerio de Saúde. Pesquisa Nacional de Demografia e Saúde da Crianza e da Mulher - PNDS 2006 - Final Report [in Portuguese]. Brasilia: Ministerio da Saúde; 2008.
30. Ministerio de Salud y Deportes, Programa Reforma de Salud, and Instituto Nacional de Estadística. Encuesta Nacional de Demografía y Salud ENDSA 2008 [in Spanish]. Calverton, MD: Macro International; 2009.
31. Rodriquez J, Ruiz F, Peñaloza E, etal. Encuesta Nacional de Salud 2007. Resultados Nacionales [in Spanish]. Bogotá, Colombia: Ministerio de la Protección Social; 2009.
32. Pérez F, Carrasco E, Santos JL, etal. Prevalencia de obesidad, hipertensión arterial y dislipidemia en grupos aborígenes rurales de Chile [in Spanish]. Rev Med Chil. 1999;127:1169-1175.
33. Centro de Estudios de Población y Desarrollo Social (CEPAR). Encuesta Demográfica y de Salud Materna e Infantil 2004 [in Spanish]. Quito, Ecuador: Centro de Estudios de Población y Desarrollo Social (CEPAR); 2005.
34. Instituto Cuánto. Peru National Living Standards Measurement Survey 2000. Lima, Peru: Instituto Cuánto. Available at: http://www.healthmetricsandevaluation.org/ghdx/record/peru-national-living-standards-measurement-survey-2000. Accessed 12 November 2012.
35. Pisabarro R, Irrazabal E, Recalde A. Primera encuesta nacional de sobrepeso y obesidad (ENSO I) [in Spanish]. Rev Med Urug. 2000;16:31-38.
36. Howard N, Archibald J, Ennis M, and the Caribbean Food and Nutrition Institute. FAO - Nutrition Country Profiles: Guyana. 2003; Available at: http://www.bvsde.paho.org/texcom/nutricion/guymap.pdf. Accessed 10 November 2012.
37. Figueredo R. Prevalencia de obesidad y distribución de la grasa corporal en una población urbana adulta de Paraguay. In: Braguinsky J, Alvarez Cordero R, Valenzuela A, eds. Obesidad; un desafío para América Latina [in Spanish]. Buenos Aires: El Ateneo; 2002.
38. Ennis M, and the Caribbean Food and Nutrition Institute. FAO - Nutrition Country Profiles: Trinidad and Tobago. 2003; Available at: http://www.bvsde.paho.org/texcom/nutricion/trimap.pdf. Accessed 10 November 2012.
39. Pisabarro R, Gutiérrez M, Bermúdez C, etal. Segunda Encuesta Nacional de Sobrepeso y Obesidad (ENSO 2) adultos (18-65 años o más) [in Spanish]. Rev Med Urug. 2009;25:14-26.
40. Braguinsky J, Sereday M, Cobeñas C, etal. Unexpected prevalence of obesity and associated metabolic risk factors in a medium size city (Venado Tuerto) of Argentina. Int J Obes Met Disord. 1998;22(Suppl 3):S215.
41. De Loredo L, Luquez H, Madoery R, etal. Hypertension prevalence in the Dean Funes Communitary Study. Hypertension. 1997;29:846.
42. Navarro A, Muñoz SE, Díaz MP, etal. Meat cooking habits and risk of colorectal cancer in Cordoba, Argentina. Nutrition. 2004;20:873-877.
43. Ros Pérez M, Medina-Gómez G. Obesity, adipogenesis and insulin resistance [in Spanish]. Endocrinol Nutr. 2011;58:360-369.
44. Das UN. Obesity: genes, brain, gut, and environment. Nutrition. 2010;26:459-473.
45. Tooke J. The association between insulin resistance and endotheliopathy. Diabetes Obes Metab. 1999;1(Suppl 1):17-22.
46. Dain A, Repossi G, Das UN, etal. Role of polyunsaturated fatty acids, the precursors of endocannabinoids, in human obesity and diabetes development. Front Biosci. 2010;2:1432-1447.
47. Das UN, Repossi G, Dain A, etal. L-arginine, nitric oxide and asymmetrical dimethylarginine in hypertension and type 2 diabetes mellitus. Front Biosci. 2011;16:13-20.
48. Miranda Garduño L, Reza Albarrán A. Obesidad, inflamación y diabetes [in Spanish]. Gac Med Mex. 2008;144:39-46.
49. Stumvoll M, Goldstein BJ, Van Haeften TW. Type 2 diabetes: principles of pathogenesis and therapy. Lancet. 2005;365:1333-1346.
50. Choi SH, Ginsberg HN. Increased very low density lipoprotein (VLDL) secretion, hepatic steatosis, and insulin resistance. Trends Endocrinol Metab. 2011;22:353-363.
51. Das UN, Repossi G, Dain A, etal. Is insulin resistance a disorder of the brain? Front Biosci. 2011;16:1-12.
52. Das UN, Puskás LG. Transgenic fat-1 mouse as a model to study the pathophysiology of cardiovascular, neurological and psychiatric disorders. Lipids Health Dis. 2009;8:61-72.
53. Steinberger J, Daniels SR. Obesity, insulin resistance, diabetes, and cardiovascular risk in children. Circulation. 2003;107:1448-1453.
54. Golay A, Munger R, Felber JP. Obesity and NIDDM: the retrograde regulation concept. Diabetes Rev. 1997;5:69-82.
55. Das UN. Interaction(s) of polyunsaturated fatty acids with dietary protein and its relationship to the pathogenesis of hypertension. Am J Hypertens. 2010;23:111-112.
56. Escobedo J, Schargrodsky H, Champagne B, etal. Prevalence of the metabolic syndrome in Latin America and its association with sub-clinical carotid atherosclerosis: the CARMELA cross sectional study. Cardiovasc Diabetol. 2009;8:52-60.
57. Luquez H, De Loredo L, Madoery RJ, etal. Síndrome metabólico: prevalencia en dos comunidades de Córdoba, Argentina, de acuerdo con definiciones ATP-III y OMS [in Spanish]. Rev Fed Arg Cardiol. 2005;34:80-95.
58. Sempértegui F, Estrella B, Tucker KL, etal. Metabolic syndrome in the elderly living in marginal peri-urban communities in Quito, Ecuador. Public Health Nutr. 2011;14:758-767.
59. Ryder E, Silva E, Sulbarán T, etal. Black Hispanics have a worse cardiovascular risk profile than mixed Hispanics in Venezuela. Invest Clin. 2007;48:45-55.
60. Bustos P, da Silva AA, Amigo H, etal. Metabolic syndrome in young adults from two socioeconomic Latin American settings. Nutr Metab Cardiovasc Dis. 2007;17:581-589.
61. Cárdenas Quintana H, Sánchez Abanto J, Roldán Arbieto L, etal. Prevalence of metabolic syndrome in people 20 years old and more. Peru, 2005 [in Spanish]. Rev Esp Salud Publica. 2009;83:257-265.
62. Mujica V, Leiva E, Icaza G, etal. Evaluation of metabolic syndrome in adults of Talca city, Chile. Nutr J. 2008;15:14-20.
63. De Loredo L, Steinacher M, Carri D, etal. Prevalence of insulin resistance and its association with type 2 diabetes and other cardiovascular risk factors. Rev Fac Cienc Med Cordoba. 2004;61(Suppl):26-37.
64. Figueiredo Neto JA, Figuerêdo ED, Barbosa JB, etal. Metabolic syndrome and menopause: cross-sectional study in gynecology clinic. Arq Bras Cardiol. 2010;95:339-345.
65. Ezenwaka CE, Nwagbara E, Seales D, etal. A comparative study of the prevalence of the metabolic syndrome and its components in type 2 diabetic patients in two Caribbean islands using the new International Diabetes Federation definition. Arch Physiol Biochem. 2007;113:202-210.
66. Hidalgo LA, Chedraui PA, Morocho N, etal. The metabolic syndrome among postmenopausal women in Ecuador. Gynecol Endocrinol. 2006;22:447-454.
67. Soutelo J, Saban M, Quevedo V, etal. Metabolic syndrome in Argentine women: ATPIII, IDF, IDF/AHA/NHLBI; what criterion should be used? Gynecol Endocrinol. 2011;27:448-451.
68. Howard B. Obesidad y metabolismo de las lipoproteínas: relación con la enfermedad cardiovascular [in Spanish]. In: Fletcher G, Grundy S, Hayman L, eds. Obesidad: Impacto en la Enfermedad Cardiovascular. American Heart Association monograph series, 1st ed. Buenos Aires: American Heart Association; 2001:157-169.
69. Després JP, Moorjani S, Lupien PJ, etal. Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease. Arteriosclerosis. 1990;10:497-511.
70. Lemieux I, Pascot A, Couillard C, etal. Hypertriglyceridemic waist: a marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men? Circulation. 2000;102:179-184.
71. Castelli W. Epidemiology of coronary heart disease: the Framingham study. Am J Med. 1984;76:4-12.
72. Kinney BP, Qiao L, Levaugh JM, etal. B56 alpha/protein phosphatase 2A inhibits adipose lipolysis in high-fat diet-induced obese mice. Endocrinology. 2010;151:3624-3632.
73. Garg A, Helderman JH, Koffler M, etal. Relationship between lipoprotein levels and in vivo insulin action in normal young white men. Metabolism. 1988;37:982-987.
74. Egusa G, Beltz WF, Grundy SM, etal. The influence of obesity on the metabolism of apolipoprotein B in men. J Clin Invest. 1985;76:596-603.
75. Kuller L. Epidemiología de la obesidad en los adultos en relación con la enfermedad cardiovascular [in Spanish]. In: Fletcher G, Grundy M, Hayman L, eds. Obesidad: Impacto en la Enfermedad Cardiovascular. American Heart Association monograph series, 1st ed. Buenos Aires: American Heart Association; 2001:3-32.
76. National Institutes of Health. Atherosclerosis. 2012; Available at: http://www.nlm.nih.gov/medlineplus/atherosclerosis.html. Accessed 31 October 2012.
77. Tribble D, Krauss R. Enfermedad cardiovascular ateroesclerótica [in Spanish]. In: Bowman B, Russell R, eds. Conocimientos Actuales Sobre Nutrición. 8th ed. Washington, DC: Organización Panamericana de la Salud and the International Life Sciences Institute. Publicación Científica y Técnica N°592, 2003:592-601.
78. Hall JE, Brands MW, Henegar JR. Mechanisms of hypertension and kidney disease in obesity. News Physiol Sci. 1996;11:255-261.
79. Rocchini AP. The influence of obesity in hypertension. News Physiol Sci. 1990;5:254-249.
80. Jones DW, Kim JS, Andrew ME, etal. Body mass index and blood pressure in Korean men and women: the Korean National Blood Pressure Survey. J Hypertens. 1994;12:1433-1437.
81. Fiore MC, Jimenez PM, Cremonezzi D, etal. Statins reverse renal inflammation and endothelial dysfunction induced by chronic high salt intake. Am J Physiol Renal Physiol. 2011;301:F263-F270.
82. Yepez R. Obesidad [in Spanish]. In: Organización Panamericana de la Salud (OPS/OMS), ed. Equidad en la mira: la salud pública en ecuador durante las últimas décadas. Quito, Ecuador: Consejo Nacional de la Salud (CONASA); 2007:74-86.
83. Bloomgarden ZT. American Association of Clinical Endocrinologists (AACE) consensus conference on the insulin resistance syndrome: 25-26 August 2002, Washington, DC. Diabetes Care. 2003;26:933-939.
84. Sowers KM, Sowers JR. Obesity, hypertension, and vascular disease. Curr Hypertens Rep. 1999;1:140-144.
85. Wellen KE, Hotamisligil GS. Obesity-induced inflammatory changes in adipose tissue. J Clin Invest. 2003;112:1785-1788.
86. Mujica V, Urzúa A, Leiva E, etal. Intervention with education and exercise reverses the metabolic syndrome in adults. J Am Soc Hypertens. 2010;4:148-153.
87. Lino MZ, Muniz PT, Siqueira KS. Prevalence of overweight and associated factors in adults: a population survey in Rio Branco, Acre State, Brazil, 2007-2008. Cad Saúde Pública (Rio de Janeiro). 2011;27:797-810.
88. Das UN. Metabolic Syndrome Pathophysiology: The Role of Essential Fatty Acids, 1st ed. Ames, IA: Wiley Blackwell; 2010.
89. Hausberg M, Mark AL, Hoffman RP, etal. Dissociation of sympathoexcitatory and vasodilator actions of modestly elevated plasma insulin levels. J Hypertens. 1995;13:1015-1021.
90. Rondinone CM. Adipocyte-derived hormones, cytokines, and mediators. Endocrine. 2006;29:81-90.
91. Rahmouni K, Correia MLG, Haynes WG, etal. Obesity-associated hypertension: new insights into mechanisms. Hypertension. 2005;45:9-14.
92. Jahangir E, Comandé D, Rubinstein A. Cardiovascular disease research in Latin America: a comparative bibliometric analysis. World J Cardiol. 2011;3:383-387.
93. Pan American Health Organization/World Health Organization. 2010 Basic Country Health Profiles for the Americas. 2010; Available at: http://www.paho.org/English/DD/AIS/cp_index.htm. Accessed 31 October 2012.
94. Rodríguez T, Malvezzi M, Chatenoud L, etal. Trends in mortality from coronary heart and cerebrovascular diseases in the Americas: 1970-2000. Heart 2006;92:453-460.
95. Oviedo G, Morón de Salim M, Solano L. Obesity anthropometrics indicators and the association with coronary ischemic disease. Nutr Hosp. 2006;21:694-698.
96. Ruiz-Fernández N, Espinoza M, Barrios E, etal. Cardiometabolic factors in a community located at Valencia City, Venezuela. Rev Salud Publica (Bogota). 2009;11:383-394.
97. Herrera VM, Casas JP, Miranda JJ, etal. Interethnic differences in the accuracy of anthropometric indicators of obesity in screening for high risk of coronary heart disease. Int J Obes (Lond). 2009;33:568-576.
98. Medina-Lezama J, Pastorius CA, Zea-Diaz H, etal. Optimal definitions for abdominal obesity and the metabolic syndrome in Andean Hispanics: the PREVENCION study. Diabetes Care. 2010;33:1385-1388.
99. Lizarzaburu JL, Palinkas LA. Immigration, acculturation, and risk factors for obesity and cardiovascular disease: a comparison between Latinos of Peruvian descent in Peru and in the United States. Ethn Dis. 2002;12:342-352.
100. Lindgärde F, Ercilla MB, Correa LR, etal. Body adiposity, insulin, and leptin in subgroups of Peruvian Amerindians. High Alt Med Biol. 2004;5:27-31.
101. Pereira JC, Barreto SM, Passos VMA. Perfil de risco cardiovascular e autoavaliação da saúde no Brasil: estudo de base populacional [in Portuguese]. Rev Panam Salud Publica. 2009;255:491-498.
102. Campana EM, Brandão AA, Pozzan R, etal. Blood pressure in young individuals as a cardiovascular risk marker. The Rio de Janeiro study. Arq Bras Cardiol. 2009;93:608-615, 657-665.
103. Longo GZ, Neves J, Luciano VM, etal. Prevalence of high blood pressure levels and associated factors among adults in Southern Brazil. Arq Bras Cardiol. 2009;93:387-394.
104. Barbosa JB, Silva AA, Santos AM, etal. Prevalence of arterial hypertension and associated factors in adults in São Luís, state of Maranhão. Arq Bras Cardiol. 2008;91:236-242.
105. Gulliford MC, Mahabir D, Rocke B. Socioeconomic inequality in blood pressure and its determinants: cross-sectional data from Trinidad and Tobago. J Hum Hypertens. 2004;18:61-70.
106. Díaz ME. Hypertension and obesity. J Hum Hypertens. 2002;16(Suppl 1):S18-S22.
107. Jiménez JT, Palacios M, Cañete F, etal. Prevalence of diabetes mellitus and associated cardiovascular risk factors in an adult urban population in Paraguay. Diabet Med. 1998;15:334-338.
108. Ramirez MO, Pino CT, Furiasse LV, etal. Paraguayan National Blood Pressure Study: prevalence of hypertension in the general population. J Hum Hypertens. 1995;9:891-897.
109. Fleischer NL, Diez Roux AV, Alazraqui M, etal. Social patterning of chronic disease risk factors in a Latin American city. J Urban Health 2008;85:923-927.
110. Rubinstein A, Colantonio L, Bardach A, etal. Estimación de la carga de las enfermedades cardiovasculares atribuible a factores de riesgo modificables en Argentina [in Spanish]. Rev Panam Salud Publica. 2010;27:237-245.
111. Rubinstein AL, Irazola VE, Poggio R, etal. Detection and follow-up of cardiovascular disease and risk factors in the Southern Cone of Latin America: the CESCAS I study. BMJ. 2011;1:e000126.
112. Krukowski RA, West DS. Consideration of the food environment in cancer risk reduction. J Am Diet Assoc. 2010;110:842-844.
113. World Cancer Research Foundation/American Institute for Cancer Research. Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective. 2007. Available at: http://www.dietandcancerreport.org/expert_report/report_contents/index.php. Accessed 10 November 2012.
114. Weinstein IB. The origins of human cancer: molecular mechanisms of carcinogenesis and their implication for cancer prevention and treatment - twenty-seventh GHA Clowes Memorial Award Lectures. Cancer Res. 1988;48:4135-4143.
115. Doll R, Peto R. The causes of cancer: quantitative estimate of available risks of cancer in the United States today. J Natl Cancer Inst. 1981;66:1191-1308.
116. Pasqualini ME, Berra MA, Yurawecz MP, etal. Dietary manipulation of precursor polyunsaturated fatty acids modulates eicosanoid and endocanabinoid synthesis: a potential tool to control tumor development. Curr Nutr Food Sci. 2008;4:161-175.
117. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100:57-70.
118. Lin WW, Karin M. Acytokine-mediated link between innate immunity, inflammation, and cancer. J Clin Invest. 2007;117:1175-1183.
119. Comba A, Pasqualini ME. Primers on molecular pathways - lipoxygenases: their role as an oncogenic pathway in pancreatic cancer. Pancreatology. 2009;9:724-728.
120. Ray LB. Inflammation and tumor progression. Sci STKE. 2007;394:tw246.
121. Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420:860-867.
122. Shacter E, Weitzman SA. Chronic inflammation and cancer. Oncology. 2002;16:217-226.
123. Fox JG, Wang TC. Inflammation, atrophy, and gastric cancer. J Clin Invest. 2007;117:60-69.
124. Dobrovolskaia MA, Kozlov SV. Inflammation and cancer: when NF-kappaB amalgamates the perilous partnership. Curr Cancer Drug Targets. 2005;5:325-344.
125. Das UN. Clinical laboratory tools to diagnose inflammation. Adv Clin Chem. 2001;41:189-229.
126. Das UN. Acetylcholinesterase and butyrylcholinesterase as possible markers of low-grade systemic inflammation. Med Sci Monit. 2007;13:RA 214-RA 221.
127. Oxenkrug GF. Metabolic syndrome, age-associated neuroendocrine disorders, and dysregulation of tryptophan-kynurenine metabolism. Ann N Y Acad Sci. 2010;1199:1-14.
128. Ye J, Keller JN. Regulation of energy metabolism by inflammation: a feedback response in obesity and calorie restriction. Aging. 2010;2:361-368.
129. LaPorte SL, Juo ZS, Vaclavikova J, etal. Molecular and structural basis of cytokine receptor pleiotropy in the interleukin-4/13 system. Cell. 2008;132:259-272.
130. Court N, Vasseur V, Vacher R, etal. Partial redundancy of the pattern recognition receptors, scavenger receptors, and C-type lectins for the long-term control of Mycobacterium tuberculosis infection. J Immunol. 2010;184:7057-7070.
131. Das UN. Can essential fatty acids reduce the burden of disease(s)? Lipids Health Dis. 2008;7:9-13.
132. Oxenkrug GF. Tryptophan kynurenine metabolism as a common mediator of genetic and environmental impacts in major depressive disorder: the serotonin hypothesis revisited 40 years later. Isr J Psychiatry Relat Sci. 2010;46:56-63.
133. Karin M, Greten FR. NF-kB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol. 2005;5:749-759.
134. Karin M. Nuclear factor-kappaB in cancer development and progression. Nature. 2006;441:431-436.
135. Comba A, Maestri DM, Berra MA, etal. Effect of ω-3 and ω-9 fatty acid rich oils on lipoxygenases and cyclooxygenases enzymes and on the growth of a mammary adenocarcinoma model. Lipids Health Dis. 2010;9:112-123.
136. Pradhan M, Bembinster LA, Baumgarten SC, etal. Proinflammatory cytokines enhance estrogen-dependent expression of the multidrug transporter gene ABCG2 through estrogen receptor and NFNB cooperativity at adjacent response elements. J Biol Chem. 2010;285:31100-31106.
137. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet. 2001;357:539-545.
138. Ben-Baruch A. Inflammation-associated immune suppression in cancer: the roles played by cytokines, chemokines and additional mediators. Semin Cancer Biol. 2006;16:38-52.
139. Micić D, Polovina S. Obesity and coronary heart disease: the mechanism of atherogenic impact [in Serbian]. Med Pregl. 2009;62 (Suppl 3):S43-S46.
140. Eynard AR, Jiang WG, Mansel RE. Eicosatrienoic acid (20:3 n-9) inhibits the expression of E-cadherin and desmoglein in human squamous cell carcinoma in vitro. Prostaglandins Leukot Essent Fatty Acids. 1998;59:371-377.
141. Thorand B, Zierer A, Baumert J, etal. Associations between leptin and the leptin/adiponectin ratio and incident type 2 diabetes in middle-aged men and women: results from the MONICA/KORA Augsburg study 1984-2002. Diabet Med. 2010;27:1004-1011.
142. Locksley RM, Killeen N, Lenardo MJ. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell. 2001;104:487-501.
143. Botey Puig A, Coca Payeras A, de la Sierra Iserte A. Hipertensión Arterial [in Spanish]. In: Farrera P, Rozman C, eds. Medicina Interna, 15th ed. Madrid: Elsevier; 2006:587-609.
144. Kishimoto T. Interleukin-6: from basic science to medicine - 40 years in immunology. Annu Rev Immunol. 2005;23:1-21.
145. Naugler WE, Sakurai T, Kim S, etal. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science. 2007;317:121-124.
146. Wei LH, Kuo ML, Chen CA, etal. The anti-apoptotic role of interleukin-6 in human cervical cancer is mediated by up-regulation of Mcl-1 through a PI 3-K/Akt pathway. Oncogene. 2001;20:5799-5809.
147. Drachenberg DE, Elgamal AA, Rowbotham R, etal. Circulating levels of interleukin-6 in patients with hormone refractory prostate cancer. Prostate. 1999;41:127-133.
148. Adler HL, McCurdy MA, Kattan MW, etal. Elevated levels of circulating interleukin-6 and transforming growth factor-beta1 in patients with metastatic prostatic carcinoma. J Urol. 1999;161:182-187.
149. Schafer ZT, Brugge JS. IL-6 involvement in epithelial cancers. J Clin Invest. 2007;117:3660-3663.
150. Twillie DA, Eisenberger MA, Carducci MA, etal. Interleukin-6: a candidate mediator of human prostate cancer morbidity. Urology. 1995;43:542-549.
151. Berishaj M, Gao SP, Ahmed S, etal. Stat3 is tyrosine-phosphorylated through the interleukin-6/glycoprotein 130/Janus kinase pathway in breast cancer. Breast Cancer Res. 2007;9:R32.
152. Aleksic T, Chitnis MM, Perestenko OV, etal. Type 1 insulin-like growth factor receptor translocates to the nucleus of human tumor cells. Cancer Res. 2010;70:6412-6419.
153. Walker MP, Diaugustine RP, Zeringue E, etal. An IGF1/insulin receptor substrate-1 pathway stimulates a mitotic kinase (cdk1) in the uterine epithelium during the proliferative response to estradiol. J Endocrinol. 2010;207:225-235.
154. Denis G, Arruda AP, Romanatto T, etal. TNF-alpha transiently induces endoplasmic reticulum stress and an incomplete unfolded protein response in the hypothalamus. Neuroscience. 2010;170:1035-1044.
155. Das UN. Gamma-linolenic acid therapy of human glioma - a review of in vitro, in vivo, and clinical studies. Med Sci Monit. 2007;13:RA119-RA131.
156. Center MM, Jemal A, Ward E. International trends in colorectal cancer incidence rates. Cancer Epidemiol Biomarkers Prev. 2009;18:1688-1894.
157. Ferlay J, Shin HR, Bray F, etal. Estimates of worldwide burden of cancer in 2008: GLOBOCON 2008. Int J Cancer. 2010;127:2893-2917.
158. Niclis C, Díaz MP, La Vecchia C. Breast cancer mortality trends and patterns in Córdoba, Argentina in the period 1986-2006. Eur J Cancer Prev. 2010;19:94-99.
159. Niclis C, Pou SA, Bengió RH, etal. Prostate cancer mortality trends in Argentina 1986-2006: an age-period-cohort and joinpoint analysis. Cad Saude Publica. 2011;27:123-130.
160. Pou SA, Osella AR, Eynard AR, etal. Colorectal cancer mortality trends in Córdoba, Argentina. Cancer Epidemiol. 2009;33:406-412.
161. Pou SA, Osella AR, Eynard AR, etal. Cancer mortality in Córdoba, Argentina, 1986-2006: an age-period-cohort analysis. Tumori. 2010;96:202-212.
162. Pou SA, Osella AR, Diaz MP. Bladder cancer mortality trends and patterns in Córdoba, Argentina (1986-2006). Cancer Causes Control. 2011;22:407-415.
163. Díaz MP, Osella AR, Aballay LR, etal. Cancer incidence pattern in Cordoba, Argentina. Eur J Cancer Prev. 2009;18:259-266.
164. Diaz MP, Corrente JE, Osella AR, etal. Modelling spatial distribution of cancer incidence in Cordoba, Argentina. Appl Cancer Res. 2010;30:12-25.
165. Lantieri MJ, Butinof M, Fernández RA, etal. Work practices, exposure assessment and geographical analysis of pesticide applicators in Argentina. In: Stoytcheva M, ed. Pesticides in the Modern World - Effects of Pesticides Exposure. Rijeka, Croatia: InTech Europe; 2011:115-138.
166. Gil Montero R, Teruel A, Massé G, etal. Capítulo Argentina y Uruguay en los albores del siglo XX. Heterogeneidades nacionales y homogeneidades transnacionales. Aportes demográficos para su interpretación [in Spanish]. In: Celton, D, Miro C, Sánchez Albornoz N, eds. Cambios demográficos en América latina: la experiencia de cinco siglos. Córdoba, Argentina: Universidad Nacional de Córdoba and Internatinal Union for Scientific Study of Population; 1998:607-640.
167. Navarro A, Muñoz SE, Eynard AR. Diet, feeding habits and risk of colorectal cancer in Córdoba. Argentina. A pilot study. J Exp Clin Cancer Res. 1995;14:287-291.
168. Navarro A, Osella AR, Muñoz SE, etal. Fatty acids, fibres and colorectal cancer risk in Córdoba, Argentina. J Epidemiol Biostat. 1998;3:415-422.
169. Navarro A, Osella AR, Muñoz SE, etal. Fibres, dietary lipids and colorectal cáncer risk in Córdoba, Argentina. J Epidemiol Biostat. 1998;3:415-423.
170. Navarro A, Diaz MP, Muñoz SE, etal. Characterisation of meat consumption and risk of colorectal cancer in Cordoba, Argentina. Nutrition. 2003;19:7-10.
171. Pou SA, Díaz MD, Osella AR. Applying multilevel model to the relationship of dietary patterns and colorectal cancer: an ongoing case-control study in Córdoba, Argentina. Eur J Nutr. 2012;51:755-764.
172. De Stefani E, Fierro L, Mendilaharsu M, etal. Meat intake, "mate" drinking and renal cell cancer in Uruguay: a case-control study. Br J Cancer. 1998;78:1239-1243.
173. Solimano G, Mazzei M. Which are the causes of death among Chileans today? Long-term perspectives. Rev Med Chil. 2007;135:932-938.
174. Atalah E, Urteaga C, Rebolledo A, etal. Breast cancer risk factors in women in Santiago, Chile. Rev Med Chil. 2000;128:137-143.
175. Ronco AL, Boeing H, De Stefani E, etal. A case-control study on fat-to-muscle ratio and risk of breast cancer. Nutr Cancer. 2009;61:466-474.
176. Ronco AL, Mendoza B, Varas X, etal. Somatotype and risk of breast cancer: a case-control study in Uruguay. Rev Bras Epidemiol. 2008;11:215-227.
177. Iscovich JM, Iscovich RB, Howe G, etal. A case-control study of diet and breast cancer in Argentina. Int J Cancer. 1989;44:770-776.
178. Pathak DR, Whittemore AS. Combined effects of body size, parity, and menstrual events on breast cancer incidence in seven countries. Am J Epidemiol. 1992;135:153-168.
179. Niclis C, Díaz MP, Eynard AR, etal. Dietary habits and prostate cancer prevention: a review of observational studies by focusing on South America. Nutr Cancer. 2012;64:23-33.
180. López Fontana C, Maselli Artola ME, Vanrell Rodríguez MC, etal. Advances on the influence of adipose tissue on prostate cancer. Actas Urol Esp. 2009;33:242-248.
181. Negrón R, Vásquez A, Nieves M, etal. Body mass index affects the diagnosis and progression of prostate cancer in Hispanics. Ethn Dis. 2010;20(Suppl 1):S1-168-12013172.
182. Iscovich JM, L'Abbé KA, Castelleto R, etal. Colon cancer in Argentina. I: risk from intake of dietary items. Int J Cancer. 1992;51:851-857.
183. Iscovich JM, L'Abbé KA, Castelleto R, etal. Colon cancer in Argentina. II: risk from fibre, fat and nutrients. Int J Cancer. 1992;51:858-861.
184. Andreatta MM, Muñoz SE, Lantieri MJ, etal. Artificial sweetener consumption and urinary tract tumors in Cordoba, Argentina. Prev Med. 2008;47:136-139.
185. Andreatta MM, Navarro A, Muñoz SE, etal. Dietary patterns and food groups are linked to the risk of urinary tract tumors in Argentina. Eur J Cancer Prev. 2010;19:478-484.
186. Villavicencio A, Aguilar G, Argüello G, etal. The effect of overweight and obesity on proliferation and activation of AKT and ERK in human endometria. Gynecol Oncol. 2010;117:96-102.